| AKT | AKT serine/threonine kinase 1 |
| AMI | Acute myocardial infarction |
| ApoE−/− | Apolipoprotein E double knockout |
| ARE | Antioxidant response elements |
| BMI | Body mass index |
| CAD | Coronary artery disease |
| CAP1 | Adenylyl cyclase-associated protein 1 |
| CaV1.2 | L-type Ca2+ channel |
| CCRL2 | C-C chemokine receptor-like 2 |
| cGMP | Cyclic guanosine monophosphate |
| CMDs | Cardiometabolic diseases |
| CMKLR1 | Chemokine-like receptor 1 |
| COX2 | Cyclooxygenase-2 |
| CRP | C-reactive protein |
| CVDs | Cardiovascular diseases |
| DCN | Decorin |
| EAT | Epicardial adipose tissue |
| ERK | Extracellular signal-regulated kinase |
| FGF-21 | Fibroblast growth factor-21 |
| eNOS | Endothelial nitric oxide synthase |
| FAS | Factor-associated suicide |
| GPR1 | G protein-coupled receptor 1 |
| GR | Glucocorticoid receptor |
| HbA1c | Glycated haemoglobin |
| HDL | High-density lipoprotein |
| HUVECs | Human umbilical vein endothelial cells |
| I/R | Ischemia/reperfusion |
| ICAM-1 | Intracellular molecular adhesion 1 |
| IFNγ | Interferon γ |
| IGF-1R | Insulin growth factor-1 receptor |
| IL | Interleukin |
| JAK | Janus kinase |
| JNK | C-Jun N-terminal kinases |
| KD | Kawasaki disease |
| LepR | Leptin receptor |
| LIF | Leukaemia inhibitory factor |
| LIFR | Leukaemia inhibitory factor receptor |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| MCP-1 | Monocyte chemoattractant protein-1 |
| Metrnl | Meteorin-like |
| MI | Myocardial infarction |
| MyD88 | Myeloid differentiation factor 88 |
| NFAT | Nuclear factor of activated T-cells |
| NF-κβ | Nuclear factor |
| NLRP3 | NOD-, LRR- and pyrin domain-containing protein 3 |
| NO | Nitric oxide |
| Nox | Nicotinamide adenine dinucleotide phosphate oxidase |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NUCB2 | Nucleobindin 2 |
| OSM | Oncostatin M |
| OSMR | Oncostatin M receptor |
| oxLDL | Oxidised low-density lipoprotein |
| PBMCs | Peripheral blood mononuclear cells |
| PECAM | Platelet endothelial cell adhesion molecule |
| PI3K | Phosphoinositide 3-kinase |
| PGE2 | Prostaglandin E2 |
| PPARδ | Peroxisome proliferator-activated receptor δ |
| PVAT | Perivascular adipose tissue |
| RARRES2 | Retinoic acid receptor responder 2 |
| ROR-1 | Tyrosine kinase-like orphan receptor 1 |
| ROS | Reactive oxygen species |
| RXFP1 | Relaxin family peptide receptor 1 |
| SAT | Subcutaneous adipose tissue |
| STAT | Signal transducer and activator of transcription protein |
| T2DM | Type 2 diabetes mellitus |
| TGF-β | Transforming growth factor β |
| TIG2 | Tazarotene-induced gene 2 |
| TLR-4 | Toll-like receptor 4 |
| TNFα | Tumour necrosis factor α |
| TXNIP | Thioredoxin-interacting protein |
| VAT | Visceral adipose tissue |
| VCAM-1 | Vascular cell molecular adhesion 1 |
| VEGF | Vascular endothelial growth factor |
| VSMCs | Vascular smooth muscle cells |
| WAT | White adipose tissue |